RANI News and Press, Rani Therapeutics Holdings Inc. From 09/13/21

- IPO in July 2021 raised $84.3 million in gross proceeds - - Talat Imran Appointed Chief Executive Officer - - Enhanced leadership team with key management and board of directors’ appointments - SAN JOSE, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Rani Therapeuti...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P (SP500) and Dow (DJI) finished up for the second week in a row. The Nasdaq (COMP.IND) ended the week down as rates steadily gained from Monday ...

SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (“Rani Therapeutics” or “Rani”), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologi...

Rani Therapeutics Holdings Inc. (NASDAQ:RANI) traded at a new 52-week high today of $21.45. This new high was reached on below average trading volume as 881,000 shares traded hands, while the average 30-day volume is approximately 0,000 shares. Rani Therapeutics Holdings Inc is a clinica...

Rani Therapeutics Holdings Inc. (NASDAQ:RANI) traded today at a new 52-week high of $29.20. So far today approximately 384,000 shares have been exchanged, as compared to an average 30-day volume of 0,000 shares. Based on a current price of $19.66, Rani Therapeutics Holdings Inc. is curre...